Position in DXCM
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$345,572
+$76,600 QoQ
Shares Held
5,131
+19.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#636
of 966 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Compound Planning, Inc. holds $15,546,398 across 8 Medical Devices names. DXCM ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
119,850 | $10,875,188 | |
| 2 | SYK |
Stryker Corp
|
7,235 | $2,277,867 | |
| 3 | MDT |
Medtronic plc
|
8,150 | $637,574 | |
| 4 | EW |
Edwards Lifesciences Corp
|
5,469 | $494,725 | |
| 5 | BSX |
Boston Scientific Corp
|
10,798 | $460,858 | |
| 6 | DXCM |
Dexcom Inc
This page
|
5,131 | $345,572 | |
| 7 | PHG |
Koninklijke Philips NV
|
9,026 | $245,416 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
2,430 | $209,198 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,572 | 5,131 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $268,972 | 4,283 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $213,512 | 3,217 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $267,814 | 3,980 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $541,372 | 6,202 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $257,521 | 3,771 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $417,935 | 5,374 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $263,869 | 3,936 | Shares | Sole | 2024-10-08 | |
| No filing history on record for this holder in this stock. | ||||||